KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 12 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $9,548,000 | -21.9% | 11,460,000 | -23.4% | 0.77% | -17.1% |
Q4 2021 | $12,230,000 | +6.9% | 14,960,000 | 0.0% | 0.93% | -13.5% |
Q3 2021 | $11,437,000 | -23.9% | 14,960,000 | -0.3% | 1.07% | -33.4% |
Q2 2021 | $15,028,000 | +60.4% | 15,000,000 | +66.7% | 1.61% | +40.9% |
Q1 2021 | $9,367,000 | – | 9,000,000 | – | 1.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 9,000,000 | $7,529,000 | 3.08% |
Context Capital Management, LLC | 16,700 | $13,919,000 | 0.90% |
Opti Capital Management, LP | 11,460,000 | $9,548,000 | 0.77% |
DeepCurrents Investment Group LLC | 22,500,000 | $18,593,000 | 0.58% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,050,000 | $24,245,000 | 0.56% |
PenderFund Capital Management Ltd. | 1,500,000 | $1,615,000 | 0.40% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $20,932,000 | 0.27% |
AQR Arbitrage LLC | 9,900,000 | $8,388,000 | 0.22% |
CSS LLC/IL | 5,000,000 | $4,154,000 | 0.15% |
Verition Fund Management LLC | 6,313,000 | $5,349,000 | 0.06% |